Dr. Jason Porter details groundbreaking research for NSCLC

Posted by & filed under Uncategorized.

Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. ūüéČ Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »

The Latest in Lung Cancer Research with Dr. Jason Porter

Posted by & filed under Uncategorized.

Tuesday, September 19 at 5pm EST Join Dr. Jason Porter for a live, dynamic discussion about the critical role of biomarker testing and clinical trials in lung cancer! Dr. Porter will partner with Estelamari Rodriguez, MD, MPH from the University of Miami’s Sylvester Comprehensive Cancer Center and moderator Terric Conneran, Founder of KRAS Kickers, to… Read more »

Exciting News in Lung Cancer Treatment, ft. Dr. Jason Porter

Posted by & filed under Uncategorized.

Exciting News in Lung Cancer Treatment   Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC).   The group talks about several new clinical trials demonstrating promising results for high… Read more »

Best of ASCO – Memphis Conference

Posted by & filed under Uncategorized.

This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »

Lung Cancer

Posted by & filed under Uncategorized.

Our lung cancer team is recognized by the community as exceptional from prevention and diagnosis to the latest treatments. Lung cancer is one of the most common types of cancer, but the good news is the growing number of new therapies. At West Cancer Center & Research Institute, our specialists can provide you with new... Read more »

2023 Top Doctors

Posted by & filed under Uncategorized.

CONGRATULATIONS TO OUR TOP DOCTORS! Castle Connolly recently announced their 2023 #TopDoc picks, and 18 of our West physicians were selected. Of over 850,000 practicing providers in the U.S., our doctors were chosen though a rigorous 3rd party research process including study of their professional qualifications, education, appointments, leadership, reputation, and disciplinary history. Patients always… Read more »

Dr. Jason Porter Hosting Lung Cancer – State of the Science Summit

Posted by & filed under Uncategorized.

Dr. Jason Porter has partnered with¬†OncLive¬†to present a Lung Cancer¬†State of the Science Summit! Academic & community-based physicians along with healthcare professionals are invited to attend this meeting on Thursday, May 11 in Nashville, TN. Attendees will expand their knowledge of novel treatment approaches and applying state-of-the-art treatment strategies. Click the link below to register… Read more »

“Diversity, Equity, and Inclusion¬†Conversations for Change”

Posted by & filed under Uncategorized.

Our West family is excited to host the upcoming “Diversity, Equity, and Inclusion¬†Conversations for Change” on Friday, March 3. Aimed to improve pathways for care and end disparities¬†in our area, Dr. Gregory Vidal and several fellow West providers invite primary care providers to this collaborative meeting. Topics include: – Barriers to Access of Cancer Care… Read more »

New Lung Screening Program

Posted by & filed under Uncategorized.

Our West Family is excited to launch a lung screening¬†program at several of our campuses across the MidSouth! Patients and referring providers can schedule an appointment to receive a low-dose CT scan to detect lung cancer early. We accept all major insurance carriers and patients must meet the following criteria: – Between the ages of… Read more »